Lundbeck
HLUN-B.CO
#2885
Rank
โ‚น368.21 B
Marketcap
โ‚น383.11
Share price
0.14%
Change (1 day)
-3.02%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): โ‚น29.01

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is โ‚น30.16. In 2022 the company made an earnings per share (EPS) of โ‚น22.93 a decrease over its 2021 EPS that were of โ‚น51.51.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น29.0126.5%
2022โ‚น22.93-55.47%
2021โ‚น51.51-51.83%
2020โ‚น106.92-28.01%
2019โ‚น148.52-44.08%
2018โ‚น265.5951.94%
2017โ‚น174.79126.64%
2016โ‚น77.12-120.84%
2015-โ‚น370.105622.18%
2014-โ‚น6.47-110.03%
2013โ‚น64.46-28.08%
2012โ‚น89.63-52.1%
2011โ‚น187.11-1.31%
2010โ‚น189.6015.61%
2009โ‚น164.00